CD274 and neoplasm: Xiang Li found that ROS decreased the amount of tumor exo-miR-155 that was taken up by macrophages, resulting in enhanced macrophage infiltration and T cell inactivation characterized by upregulation of PD-L1 in ovarian cancer47.